References
- Albarq, A. N., & Suleiman, A. K. (2021). Pharmaceutical marketing strategies’ influence on physician’s prescription behavior. Archives of Pharmacy Practice, 12(1), 7–12. https://doi.org/https://doi.org/10.51847/Z1e2zxY21k
- Beauchamp, T. L., & Childress, J. F. (2013). Principles of biomedical ethics (7th ed.).Oxford University Press.
- Brax, H., Fadlallah, R., Al-Khaled, L., Kahale, L. A., Nas, H., El-Jardali, F., & Akl, E. A. (2017). Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PLoS One, 12(4), e0175493https://doi.org/https://doi.org/10.1371/journal.pone.0175493
- Brett, A. S., Burr, W., & Moloo, J. (2003). Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med, 163(18), 2213–2218. https://doi.org/https://doi.org/10.1001/archinte.163.18.2213
- Christie, T., Groarke, L., & Sweet, W. (2008). Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate. The International Journal on Drug Policy, 19(1), 52–58. https://doi.org/https://doi.org/10.1016/j.drugpo.2007.11.020
- Dave, D., & Saffer, H. (2012). Impact of direct-to-consumer advertising on pharmaceutical prices and demand. Southern Economic Journal, 79(1), 97–126. https://doi.org/https://doi.org/10.4284/0038-4038-79.1.97
- DeFrank, J. T., Berkman, N. D., Kahwati, L., Cullen, K., Aikin, K. J., & Sullivan, H. W. (2020). Direct-to-Consumer advertising of prescription drugs and the patient-prescriber encounter: A systematic review. Health Communication, 35(6), 739–746. https://doi.org/https://doi.org/10.1080/10410236.2019.1584781
- Ferrell, O. C., Fraedrich, J., & Ferrell, L. (2019). Business ethics: Ethical decision making & cases (12th ed.). Cengage.
- Fickweiler, F., Fickweiler, W., & Urbach, E. (2017). Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review. BMJ Open, 7(9), e016408. https://doi.org/https://doi.org/10.1136/bmjopen-2017-016408
- Foot, P. (1967). The problem of abortion and the doctrine of double effect. Oxford Review, 5, 5–15.
- Groves, K. E. M., Sketris, I., & Tett, S. E. (2003). Prescription drug samples-does this marketing strategy counteract policies for quality use of medicines?Journal of Clinical Pharmacy and Therapeutics, 28(4), 259–271. https://doi.org/https://doi.org/10.1046/j.1365-2710.2003.00481.x
- Gustafson, A. (2013). In defense of a utilitarian business ethics. Business and Society Review, 118(3), 325–360. https://doi.org/https://doi.org/10.1111/basr.12013
- Huhmann, B. A., & Limbu, Y. B. (2016). Content and compliance of pharmaceutical social media marketing. Marketing Intelligence & Planning, 34(7), 977–999. https://doi.org/https://doi.org/10.1108/MIP-06-2015-0124
- Khazzaka, M. (2019). Pharmaceutical marketing strategies’ influence on physicians’ prescribing pattern in Lebanon: ethics, gifts, and samples. BMC Health Services Research, 19(1), 1–11. https://doi.org/https://doi.org/10.1186/s12913-019-3887-6
- Kim, H. (2015). Trouble spots in online direct-to-consumer prescription drug promotion: A content analysis of FDA warning letters. International Journal of Health Policy and Management, 4(12), 813–821. https://doi.org/https://doi.org/10.15171/ijhpm.2015.157
- Lee, D., & Begley, C. E. (2016). Physician report of industry gifts and quality of care. Health Care Management Review, 41(3), 275–283. https://doi.org/https://doi.org/10.1097/HMR.0000000000000042
- Mill, J. S. (1863). Utilitarianism. Parker, Son, and Bourn.
- Morgan, S., Grootendorst, P., Lexchin, J., Cunningham, C., & Greyson, D. (2011). The cost of drug development: A systematic review. Health Policy (Amsterdam, Netherlands), 100(1), 4–17. https://doi.org/https://doi.org/10.1016/j.healthpol.2010.12.002
- Mukherji, P., Raman, R. J., Dutta, S., & Rajiv, S. (2017). How direct-to-consumer advertising for prescription drugs affects consumers’ welfare. Journal of Advertising Research, 57(1), 94–108. https://doi.org/https://doi.org/10.2501/JAR-2016-050
- Nguyen, T. A., Knight, R., Roughead, E. E., Brooks, G., & Mant, A. (2015). Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries. Health Policy and Planning, 30(2), 267–280. https://doi.org/https://doi.org/10.1093/heapol/czt105
- Opdebeeck, H., & Habisch, A. (2011). Compassion: Chinese and western perspectives on practical wisdom in management. Journal of Management Development, 30(7/8), 778–788. https://doi.org/https://doi.org/10.1108/02621711111150272
- Parker, R. S., & Pettijohn, C. E. (2003). Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. Journal of Business Ethics, 48(3), 279–290. https://doi.org/https://doi.org/10.1023/B:BUSI.0000005783.58142.6e
- Parker, R. S., & Pettijohn, C. E. (2005). Pharmaceutical drug marketing strategies and tactics. Health Marketing Quarterly, 22(4), 27–43. https://doi.org/https://doi.org/10.1300/J026v22n04_03
- Petticrew, M., & Roberts, H. (2006). Systematic Reviews in the Social Sciences: A Practical Guide., Blackwell.
- Quick, J. D., Boohene, N.-A., Rankin, J., & Mbwasi, R. J. (2005). Medicines supply in Africa: Should improve through regional collaborations and accredited drug shops. BMJ (Clinical Research ed.), 331(7519), 709–710. https://doi.org/https://doi.org/10.1136/bmj.331.7519.709
- Quinn, W. (1989). Actions, intentions, and consequences: The doctrine of double effect. Philosophy & Public Affairs, 18(4), 334–351.
- Rawls, J. (1971). A theory of justice. Harvard University Press.
- Ritov, I., & Baron, J. (1990). Reluctance to vaccinate: Omission bias and ambiguity. Journal of Behavioral Decision Making, 3(4), 263–277. https://doi.org/https://doi.org/10.1002/bdm.3960030404
- Salmasi, S., Ming, L. C., & Khan, T. M. (2016). Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis. Journal of Pharmaceutical Policy & Practice, 9, 1–12. https://doi.org/https://doi.org/10.1186/s40545-016-0089-z
- Scanlon, T. M. (1998). What we owe to each other. Harvard University Press.
- Tengilimoglu, D., Kisa, A., & Ekiyor, A. (2004). The pharmaceutical sales rep/physician relationship in Turkey: Ethical issues in an international context. Health Marketing Quarterly, 22(1), 21–39. https://doi.org/https://doi.org/10.1300/j026v22n01_03
- van de Pol, P. K. C., & de Bakker, F. G. A. (2010). Direct-to-consumer advertising of pharmaceuticals as a matter of corporate social responsibility?Journal of Business Ethics, 94(2), 211–224. https://doi.org/https://doi.org/10.1007/s10551-009-0257-z
- Wande, D. P., Sangeda, R. Z., Tibalinda, P., Mutta, I. K., Mkumbwa, S., Bitegeko, A., & Kaale, E. (2019). Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021. PLoS One, 14(8), e0220701https://doi.org/https://doi.org/10.1371/journal.pone.0220701
- Womack, C. A. (2013). Ethical and epistemic issues in direct-to-consumer drug advertising: Where is patient agency?Medicine, Health Care, and Philosophy, 16(2), 275–280. https://doi.org/https://doi.org/10.1007/s11019-012-9386-8